每年出版 4 期
ISSN 打印: 0731-8898
ISSN 在线: 2162-6537
Indexed in
Mechanisms of Metastasis as Related to Receptor Tyrosine Kinases in Small-Cell Lung Cancer
摘要
Small-cell lung cancer (SCLC) is an aggressive, malignant neoplasm with a 5-year survival of less than 10%. This poor survival rate is related to a high propensity for recurrence and a high rate of metastases. Metastases initially occur in the lymph nodes and thereafter in other organs such as the lung itself, liver, adrenal glands, brain, bone, and bone marrow. The mechanisms of metastases have been better understood recently and are described in this review. Receptor tyrosine kinases (RTKs) have been identified as important therapeutic targets in non-small-cell lung cancer (such as the EGF-receptor). We have begun to identify RTKs in SCLC and have shown that c-Kit and c-Met are expressed and functional in SCLC. RTKs have also been shown to be important in the metastasis of cancer cells. The roles of RTKs in the mechanism of metastasis are detailed in this review, with special emphasis on downstream signal transduction from RTK signaling.
-
Ali R., Ozkalemkas F., Ozcelik T., Ozan U., Ozkocaman V., Tunali A., Balaban-Adim S., Small cell lung cancer presenting as acute leukaemia, Cytopathology, 16, 5, 2005. Crossref
-
Stenina Olga I, Plow Edward F, MET orchestrates cancer and blood coagulation, Nature Medicine, 11, 4, 2005. Crossref
-
Fischer Barbara, Marinov Marin, Arcaro Alexandre, Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): What have we learned so far?, Cancer Treatment Reviews, 33, 4, 2007. Crossref
-
Zhao Yutong, Natarajan Viswanathan, Lysophosphatidic acid signaling in airway epithelium: Role in airway inflammation and remodeling, Cellular Signalling, 21, 3, 2009. Crossref
-
Maulik Nilanjana, Maulik Gautam, Involvement of Receptor Tyrosine Kinases in Lung Cancer, in Phytopharmaceuticals in Cancer Chemoprevention, 20041296, 2004. Crossref
-
Li Bo, Zhao Wei-Dong, Tan Zhi-Min, Fang Wen-Gang, Zhu Li, Chen Yu-Hua, Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells, FEBS Letters, 580, 17, 2006. Crossref
-
Yan F, Shen N, Pang J, Xie D, Deng B, Molina J R, Yang P, Liu S, Restoration of miR-101 suppresses lung tumorigenesis through inhibition of DNMT3a-dependent DNA methylation, Cell Death & Disease, 5, 9, 2014. Crossref
-
Zhao Yutong, He Donghong, Stern Randi, Usatyuk Peter V., Spannhake Ernst Wm., Salgia Ravi, Natarajan Viswanathan, Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC δ and E-cadherin, Cellular Signalling, 19, 11, 2007. Crossref
-
Magkrioti Christiana, Autotaxin and lysophosphatidic acid signalling in lung pathophysiology, World Journal of Respirology, 3, 3, 2013. Crossref
-
Ray Mandira, Garcia J G, Salgia Ravi, HGF/c-MET Signaling in Advanced Cancers, in Cancer Genome and Tumor Microenvironment, 2010. Crossref
-
He Bei Ping, Wang Jian Jun, Zhang Xian, Wu Yan, Wang Miao, Bay Boon-Huat, Chang Alex Yuang-Chi, Differential Reactions of Microglia to Brain Metastasis of Lung Cancer, Molecular Medicine, 12, 7-8, 2006. Crossref
-
Riddle Nicole D., Rojiani Mumtaz V, Brem Steven, Rojiani Amyn M., Molecular Mechanisms of Central Nervous System Metastasis, in Mechanisms of Oncogenesis, 2010. Crossref
-
Kciuk Mateusz, Gielecińska Adrianna, Budzinska Adrianna, Mojzych Mariusz, Kontek Renata, Metastasis and MAPK Pathways, International Journal of Molecular Sciences, 23, 7, 2022. Crossref
-
Yan Fei, Shen Na, Pang Jiuxia, Molina Julian R., Yang Ping, Liu Shujun, The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2′-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells, Journal of Biological Chemistry, 290, 30, 2015. Crossref
-
Yan F, Shen N, Pang J, Zhao N, Deng B, Li B, Yang Y, Yang P, Molina J R, Liu S, A regulatory circuit composed of DNA methyltransferases and receptor tyrosine kinases controls lung cancer cell aggressiveness, Oncogene, 36, 50, 2017. Crossref